DE3889489T3 - Injizierbare Stoffe aus der Placenta für die Weichgewebevermehrung und ihr Verfahren zur Herstellung. - Google Patents

Injizierbare Stoffe aus der Placenta für die Weichgewebevermehrung und ihr Verfahren zur Herstellung.

Info

Publication number
DE3889489T3
DE3889489T3 DE3889489T DE3889489T DE3889489T3 DE 3889489 T3 DE3889489 T3 DE 3889489T3 DE 3889489 T DE3889489 T DE 3889489T DE 3889489 T DE3889489 T DE 3889489T DE 3889489 T3 DE3889489 T3 DE 3889489T3
Authority
DE
Germany
Prior art keywords
injectable
soft tissue
manufacture
tissue augmentation
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3889489T
Other languages
English (en)
Other versions
DE3889489D1 (de
DE3889489T2 (de
Inventor
Carl Randall Harrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INSTITUT CLAYTON DE LA RECHERCHE, GENF/GENEVE, CH
Original Assignee
INST CLAYTON de la RECH GENF G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10615189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3889489(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by INST CLAYTON de la RECH GENF G filed Critical INST CLAYTON de la RECH GENF G
Publication of DE3889489D1 publication Critical patent/DE3889489D1/de
Application granted granted Critical
Publication of DE3889489T2 publication Critical patent/DE3889489T2/de
Publication of DE3889489T3 publication Critical patent/DE3889489T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Prostheses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE3889489T 1987-04-03 1988-03-29 Injizierbare Stoffe aus der Placenta für die Weichgewebevermehrung und ihr Verfahren zur Herstellung. Expired - Lifetime DE3889489T3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878708009A GB8708009D0 (en) 1987-04-03 1987-04-03 Injectable soft tissue augmentation materials

Publications (3)

Publication Number Publication Date
DE3889489D1 DE3889489D1 (de) 1994-06-16
DE3889489T2 DE3889489T2 (de) 1994-08-25
DE3889489T3 true DE3889489T3 (de) 2003-07-24

Family

ID=10615189

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3889489T Expired - Lifetime DE3889489T3 (de) 1987-04-03 1988-03-29 Injizierbare Stoffe aus der Placenta für die Weichgewebevermehrung und ihr Verfahren zur Herstellung.

Country Status (19)

Country Link
US (1) US5002071A (de)
EP (1) EP0285370B2 (de)
JP (1) JP2643976B2 (de)
KR (1) KR960016207B1 (de)
AT (1) ATE105481T1 (de)
AU (1) AU609108B2 (de)
CA (1) CA1308033C (de)
DE (1) DE3889489T3 (de)
DK (1) DK173020B1 (de)
ES (1) ES2052709T5 (de)
FI (1) FI92906C (de)
GB (1) GB8708009D0 (de)
HK (1) HK1006677A1 (de)
IE (1) IE64226B1 (de)
IL (1) IL85923A (de)
NO (1) NO176551C (de)
NZ (1) NZ224085A (de)
PT (1) PT87150B (de)
ZA (1) ZA882306B (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017131A1 (en) * 1991-03-29 1992-10-15 Collagen Corporation Device and method for treating facial lines
DE4125400C2 (de) * 1991-07-31 2000-08-17 Edwin Klaus Verwendung von unlöslichem Kollagen zur Behandlung von degenerativen, nicht entzündlichen Gelenkprozessen
EP0632820B1 (de) * 1992-02-28 2000-05-17 Collagen Corporation Hochkonzentrierte homogenisierte kollagenzusammensetzungen
WO1994002104A1 (en) * 1992-07-21 1994-02-03 Nikolaenko Alexandr N Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it
AU4693093A (en) * 1992-07-27 1994-02-14 Haemacure Biotech Inc. Biocompatible surgical implant
US5428022A (en) * 1992-07-29 1995-06-27 Collagen Corporation Composition of low type III content human placental collagen
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
US5523291A (en) * 1993-09-07 1996-06-04 Datascope Investment Corp. Injectable compositions for soft tissue augmentation
US5676698A (en) * 1993-09-07 1997-10-14 Datascope Investment Corp. Soft tissue implant
WO1995034309A1 (en) * 1994-06-10 1995-12-21 Aktsionernoye Obschestvo Zakry Base for a medicament and a medicament based thereon (variants)
US5545217A (en) * 1995-04-20 1996-08-13 C.M. Offray & Son, Inc. Breast implant
US5750146A (en) * 1995-04-28 1998-05-12 Matrix Pharmaceutical, Inc. Translucent collagen formulations with a cytotoxic drug
US5709887A (en) * 1995-06-06 1998-01-20 Bryan, Deceased; Clifford R. Method and composition for treating tumors
US6284284B1 (en) 1995-06-06 2001-09-04 Advanced Tissue Sciences, Inc. Compositions and methods for production and use of an injectable naturally secreted extracellular matrix
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5591444A (en) * 1995-07-28 1997-01-07 Isolagen Technologies, Inc. Use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
US5881733A (en) * 1996-09-13 1999-03-16 Depuy Orthopaedic Technology, Inc. Technique for osteocartilaginous transplantation in a mammalian joint
US5964805A (en) * 1997-02-12 1999-10-12 Stone; Kevin R. Method and paste for articular cartilage transplantation
US5814328A (en) 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
CA2281758C (en) * 1997-02-20 2014-09-23 Gerigene Medical Corporation Repair of autologous tissue defects
WO1998036705A1 (en) 1997-02-20 1998-08-27 Keller Gregory S Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
US7767452B2 (en) * 1997-02-20 2010-08-03 Kleinsek Don A Tissue treatments with adipocyte cells
US6110209A (en) * 1997-08-07 2000-08-29 Stone; Kevin R. Method and paste for articular cartilage transplantation
CA2245056A1 (en) * 1997-09-25 1999-03-25 Becton, Dickinson And Company 30 gauge lancet
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6432710B1 (en) 1998-05-22 2002-08-13 Isolagen Technologies, Inc. Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
IT1301978B1 (it) * 1998-07-31 2000-07-20 Mivett Nuovi Lab Di Pavani& C Dispersioni ipertoniche acquose di collagene non frazionato, unmetodo e un dispositivo per la preparazione di dette dispersioni.
RU2245722C2 (ru) * 1999-06-22 2005-02-10 Рисерч Дивелопмент Фаундейшн Усовершенствованное раневое покрытие для улучшения заживления ран
AU1472501A (en) * 1999-11-05 2001-05-14 Gerigene Medical Corporation Augmentation and repair of age-related soft tissue defects
US7799325B2 (en) * 1999-11-05 2010-09-21 Kleinsek Donald A Removal of hypertrophic scars
US20080286242A2 (en) * 1999-11-05 2008-11-20 Donald Kleinsek Augmentation and repair of spincter defects with cells including mesenchymal cells
US20080267923A2 (en) * 1999-11-05 2008-10-30 Donald Kleinsek Hair undifferentiated cells
US20090074729A2 (en) * 1999-11-05 2009-03-19 Donald Kleinsek Augmentation and repair of spincter defects with cells including fibroblasts
US20090130066A1 (en) * 2000-11-06 2009-05-21 Gerigene Medical Corporation Augmentation and repair of sphincter defects with cells including muscle cells
US7119062B1 (en) 2001-02-23 2006-10-10 Neucoll, Inc. Methods and compositions for improved articular surgery using collagen
WO2003020327A2 (en) * 2001-09-06 2003-03-13 Bone Sa A cross-linked collagenous biomaterial
WO2004026244A2 (en) * 2002-09-18 2004-04-01 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
US7067123B2 (en) * 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US6932840B1 (en) * 2004-09-08 2005-08-23 Absolute Breast Solutions Implant device
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7905826B2 (en) * 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
US20060100138A1 (en) * 2004-11-10 2006-05-11 Olsen David R Implantable collagen compositions
WO2006062976A2 (en) 2004-12-07 2006-06-15 Cook Incorporated Methods for modifying vascular vessel walls
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
AU2006282754A1 (en) 2005-08-26 2007-03-01 Zimmer, Inc. Implants and methods for repair, replacement and treatment of joint disease
US20070065415A1 (en) * 2005-09-16 2007-03-22 Kleinsek Donald A Compositions and methods for the augmentation and repair of defects in tissue
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8182841B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods
ES2747978T3 (es) 2005-10-03 2020-03-12 Mark A Pinsky Liposomas no fosfolipídicos que comprenden ácido hialurónico
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
EP2134297B1 (de) 2007-04-12 2017-03-08 Zimmer, Inc. Vorrichtung zur gewebereparatur
EP1997457B1 (de) * 2007-06-01 2010-11-10 Allergan, Inc. Gerät zur Erzeugung des zugspannungsinduzierten Wachstums von biologischem Gewebe
US20090054350A1 (en) * 2007-08-23 2009-02-26 Jean-Louis Tayot Process for the sterile concentration of collagen preparations, and collagen preparations obtained
EP2265220A1 (de) * 2008-03-05 2010-12-29 Musculoskeletal Transplant Foundation Spongiosa-konstrukte, knorpelteilchen und kombinationen von spongiosa-konstrukten und knorpelteilchen
EP3020410A1 (de) 2008-04-18 2016-05-18 Collplant Ltd. Verfahren zur regeneration und verwendung von prokollagen
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
US20110129520A1 (en) * 2008-04-25 2011-06-02 Simon Bogdansky Anti-Adhesion Barrier Wound Dressing Comprising Processed Amniotic Tissue and Method of Use
FR2937244B1 (fr) * 2008-10-22 2011-11-18 Sofradim Production Implant de remplacement de tendon a base de collagene
DK2380979T3 (da) 2008-12-22 2015-06-22 Univ Hokkaido Nat Univ Corp Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling
US20100274362A1 (en) * 2009-01-15 2010-10-28 Avner Yayon Cartilage particle tissue mixtures optionally combined with a cancellous construct
DK2421901T3 (en) 2009-04-24 2016-01-11 Tissue Tech Inc Compositions comprising HC-HA complex, and methods of use thereof
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US20120189586A1 (en) * 2011-01-21 2012-07-26 Carl Randall Harrell Human Placental Derived Extracellular Matrix and Uses Therof
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
US9682044B2 (en) 2011-06-10 2017-06-20 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
US8932805B1 (en) 2011-10-31 2015-01-13 BioDlogics, LLC Birth tissue material and method of preparation
US20230270916A1 (en) * 2012-03-14 2023-08-31 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
US10576037B2 (en) * 2012-03-14 2020-03-03 MAM Holdings of West Florida, L.L.C. Compositions comprising placental collagen for use in wound healing
US20180126033A9 (en) 2012-03-14 2018-05-10 MAM Holdings of West Florida, L.L.C. Collagen compositions and uses for biomaterial implants
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US11077229B1 (en) 2013-03-08 2021-08-03 BioDlogics, LLC Implant coating composition and method of use
US10016459B1 (en) 2013-03-13 2018-07-10 BioDlogics, LLC Platelet-rich plasma derived from human umbilical cord blood
US9795639B1 (en) 2013-03-16 2017-10-24 BioDlogics, LLC Methods for the treatment of erectile dysfunction by human birth tissue material compostion
US10555897B1 (en) 2013-03-16 2020-02-11 Brahm Holdings Llc Cosmetic composition and methods of treatment
US9993506B1 (en) 2013-03-16 2018-06-12 BioDlogics, Inc. Methods for the treatment of degenerative disc diseases by human birth tissue material composition
US10039792B1 (en) 2013-03-16 2018-08-07 Brahm Holdings, Llc Methods for the treatment of inflammation and pain using human birth tissue material composition
US10485521B2 (en) * 2013-05-10 2019-11-26 MAM Holdings of West Florida, L.L.C. Method for obtaining sterile human amniotic fluid and uses thereof
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US10201573B1 (en) 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
US10265438B1 (en) 2014-11-03 2019-04-23 BioDlogics, LLC Methods and compositions for the repair and replacement of connective tissue
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
CA2984443A1 (en) 2015-05-20 2016-11-24 Tissuetech, Inc. Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
EP3297694A1 (de) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modifizierte demineralisierte kortikale knochenfasern
US10173027B2 (en) 2015-10-07 2019-01-08 Cook Medical Technologies Llc Methods, medical devices and kits for modifying the luminal profile of a body vessel
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1699479A (en) * 1928-04-27 1929-01-15 Lilly Co Eli Amniotic fluid and process of preparing it
DE2405002B2 (de) * 1974-02-02 1979-07-19 Fa. H. Trommsdorff, 5110 Alsdorf Lösliches natives Kollagen aus menschlicher Plancenta sowie dieses als therapeutischen Wirkstoff enthaltendes Mittel
US4042117A (en) * 1975-07-07 1977-08-16 Buckeye International, Inc. Wear plate
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
US4446234A (en) * 1981-10-23 1984-05-01 The United States Of America As Represented By The Department Of Health And Human Services Vitro cellular interaction with amnion membrane substrate
GB2110531B (en) * 1981-11-05 1985-05-01 East Grinstead Research Trust Wound healing composition prepared from amnion
US4424208A (en) * 1982-01-11 1984-01-03 Collagen Corporation Collagen implant material and method for augmenting soft tissue
FR2530955B1 (fr) * 1982-07-30 1987-11-13 Hecmati Michel Implant anti-ride et son procede de fabrication
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4699788A (en) * 1984-08-20 1987-10-13 Trustees Of Boston University Angiogenic factor methods of extraction and method for producing angiogenesis
US4863733A (en) * 1985-08-28 1989-09-05 Startz Jack P Method of preparing treatment compositions for use in plastic or cosmetic surgery
JPH0764878B2 (ja) * 1986-10-14 1995-07-12 興和株式会社 抗血液凝固物質及びその製法
US4865602A (en) * 1986-11-06 1989-09-12 Collagen Corporation Gamma irradiation of collagen/mineral mixtures
US4795459A (en) * 1987-05-18 1989-01-03 Rhode Island Hospital Implantable prosthetic device with lectin linked endothelial cells

Also Published As

Publication number Publication date
AU609108B2 (en) 1991-04-26
DE3889489D1 (de) 1994-06-16
PT87150A (pt) 1988-04-01
EP0285370B1 (de) 1994-05-11
ES2052709T5 (es) 2003-05-16
EP0285370A3 (en) 1989-12-13
IE64226B1 (en) 1995-07-26
ZA882306B (en) 1990-02-28
DK178988D0 (da) 1988-03-30
EP0285370B2 (de) 2002-12-11
PT87150B (pt) 1992-07-31
DE3889489T2 (de) 1994-08-25
FI881518A (fi) 1988-10-04
IL85923A0 (en) 1988-09-30
US5002071A (en) 1991-03-26
NO881406D0 (no) 1988-03-29
NO176551B (no) 1995-01-16
IE880946L (en) 1988-10-03
KR880012234A (ko) 1988-11-26
KR960016207B1 (ko) 1996-12-06
JP2643976B2 (ja) 1997-08-25
EP0285370A2 (de) 1988-10-05
NO881406L (no) 1988-10-04
IL85923A (en) 1993-04-04
DK173020B1 (da) 1999-11-15
ES2052709T3 (es) 1994-07-16
ATE105481T1 (de) 1994-05-15
GB8708009D0 (en) 1987-05-07
CA1308033C (en) 1992-09-29
FI92906C (fi) 1995-01-25
NZ224085A (en) 1990-08-28
DK178988A (da) 1988-10-04
FI92906B (fi) 1994-10-14
AU1408588A (en) 1988-10-06
FI881518A0 (fi) 1988-03-31
HK1006677A1 (en) 1999-03-12
NO176551C (no) 1995-04-26
JPH01256967A (ja) 1989-10-13

Similar Documents

Publication Publication Date Title
DE3889489T3 (de) Injizierbare Stoffe aus der Placenta für die Weichgewebevermehrung und ihr Verfahren zur Herstellung.
DE68928934T2 (de) Verfahren zur herstellung von menschlicher dnase
DE3871933D1 (de) Gewebedehneinrichtung und verfahren zur herstellung und zum gebrauch.
DD131452A5 (de) Verfahren und vorrichtung zur herstellung von steril filtrierten blutgerinnungsfaktoren
DE3879218D1 (de) Medizinisches instrument und verfahren zur herstellung.
ATE14073T1 (de) Verfahren zur herstellung medizinischer und zahntechnischer alloplastischer, endo- und exoprothetischer passkoerper.
CH472219A (de) Hochporöse Kollagen-Gewebe-Blutgefässprothese und Verfahren zur Herstellung derselben
DE69417099T2 (de) Glasmaterial, Ersatz für lebendes Gewebe, Verfahren zur Herstellung eines Ersatzes für lebendes Gewebe und Anlage zum Formpressen dieses Ersatzes
AT356262B (de) Verfahren zur herstellung von mitteln zur verbesserung der durchblutung und wundheilung
ATE44878T1 (de) Verfahren zur herstellung eines kollagen-vlieses.
DE68923423D1 (de) Antithromotisches medizinisches Material, künstliches inneres Organ und Verfahren zur Herstellung eines antithrombotischen medizinischen Materials.
ATE21215T1 (de) Verfahren zur behandlung der haut und geraet zur anwendung dieses verfahrens.
AT347571B (de) Enossales implantat zur befestigung von festsitzendem zahnersatz, vorrichtung zum pass- genauen herstellen von ausfraesungen dafuer sowie versenkinstrument zum versenken des implantats
AT361129B (de) Verfahren zur herstellung eines kollagen-haut- verbandmaterials
AT364173B (de) Verfahren zur herstellung eines hartstoffes und verwendung des hergestellten hartstoffes
ATA467973A (de) Verfahren zur herstellung von in den menschlichen korper einpflanzbaren, kunstlichen organen, organteilen, organabschnitten od.dgl.
AT298664B (de) Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper
AT363175B (de) Verfahren zur erzeugung der aktiven substanz eines antilithiaticums, das antilithiaticum, und dessen anwendung zur behandlung der nierensteinkrankheit
DE3865484D1 (de) Verfahren zur herstellung von urantetrafluorid und von schwefelfluoriden mittels redoktion von uranhexafluorid.
DE58902682D1 (de) Verfahren zur herstellung eines elektrolyten zur erzeugung von alkalidichromaten und chromsaeure.
DD131048A5 (de) Verfahren und vorrichtung zur herstellung mehrschichtiger gewebe
DE3770763D1 (de) Verfahren und vorrichtung zum herstellen von einsaetzen fuer die rekonstruktion von zaehnen oder fuer andere prothetik.
ATA407280A (de) Verfahren zur herstellung von neuen imidazolinyl- saeuren und den optischen isomeren sowie isomeren- gemischen hiervon

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: INSTITUT CLAYTON DE LA RECHERCHE, GENF/GENEVE, CH